EMMA Emmaus Life Sciences Inc

Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT:  https://tinyurl.com/LSIF032620-PostAgendaPR

March 26th Presenting Companies:

Company	Ticker
RedHill Biopharma Ltd.	Nasdaq: RDHL
Nuvo Pharmaceuticals Inc.	OTCQX: NRIFF | TSX: NRI
Orexo AB	OTCQX: ORXOY | Nasdaq STO: ORX
Emmaus Life Sciences, Inc.	OTCQB: EMMA
Moleculin Biotech, Inc.	Nasdaq: MBRX
Lexaria Bioscience Corp.	OTCQX: LXRP | CSE: LXX
Beroni Group Ltd.	OTCQX: BNIGF | NSX: BTG

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor Forum

Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com